SlideShare a Scribd company logo
1 of 4
Download to read offline
The Pharmaceutical Market: Czech Republic
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CZECH REPUBLIC
The recent measures proposed by the Czech Republic's Ministry of Health will, in all likelihood, negatively affect the Czech pharmaceutical market. The
introduction of reimbursement ceilings, blind bidding auctions and preferential prescribing will squeeze drugmakers' margins and shift some of the burden of
healthcare spending onto the private sector. The outcome of similar measures in Hungary and Poland strongly supports our view that the business environment
for drugmakers will worsen if these proposals are adopted. It is patients who, ultimately, will suffer.
Headline Expenditure Projections
Pharmaceuticals: CZK80.71bn (US$4.56bn) in 2011 to CZK79.76bn (US$4.2bn) in 2012; -1.2% in local currency terms and -7.1% in US dollar terms.
Healthcare: CZK298.49bn (US$16.88bn) in 2011 to CZK297.87bn (US$15.831bn) in 2012; +0.4% in local currency terms and -8.4% in US dollar terms.
Medical Devices: CZK26.51n (US$1.50bn) in 2011 to CZK26.91bn (US$1.43bn) in 2012; +1.5% in local currency terms and -4.6% in US dollar terms. Forecast
moderat ely down due to macroeconomic factors.
Risk/Reward Rating
The Czech Republic retains its leading position in the CEE RRRs in Q113, after displacing Poland in our Q412 assessment. Despite leading in our regional RRR
table, the outlook for growth for the Czech pharmaceutical market is not particularly robust, as a result of pricing pressure, impeded market entry and increasing
generic substitution. An increase in VAT and a stringent reference pricing system have affected sales and hit manufacturers' margins respectively.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical
sector, as well as the OTC, generics, and distribution sub-sectors
table Of Contents
executive Summary 7
swot Analysis 9
czech Republic Pharmaceuticals And Healthcare Industry Swot 9
czech Republic Political Swot 10
czech Republic Economic Swot 10
czech Republic Business Environment Swot 10
pharmaceuticals Risk/reward Ratings 11
table: Central And Eastern Europe Pharmaceuticals Risk/reward Ratings, Q213 11
rewards 12
risks 12
czech Republic - Market Summary 14
regulatory Regime 16
intellectual Property Environment 16
prescribing Rules 17
pharmaceutical Advertising 17
The Pharmaceutical Market: Czech Republic
pricing Regime 18
reimbursement Regime 19
recent Pricing And Reimbursement Developments 20
changes To Vat 22
table: European Vat Rates On Medicines (%) 23
industry Developments 25
epidemiology 25
healthcare Sector 26
healthcare Insurance 26
healthcare Reforms 27
hospital Sector 28
research & Development Sector 29
clinical Trials 30
medical Devices 31
industry Forecast Scenario 33
overall Market Forecast 33
table: Czech Pharmaceutical Sales, Historical Data And Forecasts 34
key Growth Factors - Industry 35
table: Czech Healthcare Expenditure Trends, Historical Data And Forecasts 36
table: Czech Government Healthcare Expenditure Trends, Historical Data And Forecasts 37
table: Czech Private Healthcare Expenditure Trends, Historical Data And Forecasts 37
key Growth Factors - Macroeconomic 38
prescription Drug Market Forecast 42
table: Czech Prescription Drug Market Indicators, Historical Data And Forecasts 43
patented Drug Market Forecast 44
table: Czech Patented Drug Market Indicators, Historical Data And Forecasts 45
generic Drug Market Forecast 46
table: Czech Generics Drug Market Indicators, Historical Data And Forecasts 46
The Pharmaceutical Market: Czech Republic
otc Medicine Market Forecast 48
table: Czech Over-the-counter (otc) Medicine Market Indicators, Historical Data And Forecasts 50
pharmaceutical Trade Forecast 51
table: Czech Pharmaceutical Trade Data And Forecasts (us$mn) 52
table: Czech Pharmaceutical Trade Data And Forecasts (czkmn) 52
other Healthcare Data Forecasts 53
key Risks To Bmi's Forecast Scenario 53
competitive Landscape 54
pharmaceutical Sector 54
foreign Pharmaceutical Players 55
company Developments 55
pharmaceutical Wholesale 56
pharmaceutical Retail 57
table: Retail Pharmacy Market Overview, 2004-2010 57
pharmaceutical Distribution Developments 59
distance Selling Of Pharmaceuticals 60
company Profiles 61
local Companies 61
zentiva (sanofi) 61
walmark 64
multinational Companies 67
astrazeneca 67
bristol-myers Squibb 68
sanofi 69
novartis 71
glaxosmithkline 72
The Pharmaceutical Market: Czech Republic
pfizer 74
demographic Outlook 75
table: Czech Republic's Population By Age Group, 1990-2020 ('000) 76
table: Czech Republic's Population By Age Group, 1990-2020 (% Of Total) 77
table: Czech Republic's Key Population Ratios, 1990-2020 78
table: Czech Republic's Rural And Urban Population, 1990-2020 78
glossary 79
bmi Methodology 81
how We Generate Our Pharmaceutical Industry Forecasts 81
pharmaceuticals Risk/reward Ratings Methodology 82
ratings Overview 82
table: Pharmaceutical Business Environment Indicators 83
weighting 84
table: Weighting Of Components 84
sources 84
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
The Pharmaceutical Market: Czech Republic

More Related Content

More from Ambikabasa

More from Ambikabasa (20)

Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 

Recently uploaded

zidauu _business communication.pptx /pdf
zidauu _business  communication.pptx /pdfzidauu _business  communication.pptx /pdf
zidauu _business communication.pptx /pdf
zukhrafshabbir
 
(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...
(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...
(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...
Spesiialis Kandungan BPOM
 
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFRATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
CaitlinCummins3
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
seri bangash
 
Powerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metricsPowerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metrics
CaitlinCummins3
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Pusat Herbal Resmi BPOM
 
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
daisycvs
 

Recently uploaded (20)

zidauu _business communication.pptx /pdf
zidauu _business  communication.pptx /pdfzidauu _business  communication.pptx /pdf
zidauu _business communication.pptx /pdf
 
Global Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfGlobal Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdf
 
(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...
(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...
(( wa 0851/7541/5434 )) Jual Obat Aborsi Di Surabaya - Cytotec Misoprostol 20...
 
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFRATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
 
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.docGuide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
 
stock price prediction using machine learning
stock price prediction using machine learningstock price prediction using machine learning
stock price prediction using machine learning
 
Powerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metricsPowerpoint showing results from tik tok metrics
Powerpoint showing results from tik tok metrics
 
wagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIwagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORI
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
 
HAL Financial Performance Analysis and Future Prospects
HAL Financial Performance Analysis and Future ProspectsHAL Financial Performance Analysis and Future Prospects
HAL Financial Performance Analysis and Future Prospects
 
Inside the Black Box of Venture Capital (VC)
Inside the Black Box of Venture Capital (VC)Inside the Black Box of Venture Capital (VC)
Inside the Black Box of Venture Capital (VC)
 
How Do Venture Capitalists Make Decisions?
How Do Venture Capitalists Make Decisions?How Do Venture Capitalists Make Decisions?
How Do Venture Capitalists Make Decisions?
 
Your Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptxYour Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptx
 
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxBlinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
 
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
 
بروفايل شركة ميار الخليج للاستشارات الهندسية.pdf
بروفايل شركة ميار الخليج للاستشارات الهندسية.pdfبروفايل شركة ميار الخليج للاستشارات الهندسية.pdf
بروفايل شركة ميار الخليج للاستشارات الهندسية.pdf
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future world
 
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
 
5 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
5 Brilliant Ways To Buy Verified Payoneer Accounts In 20245 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
5 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
 

The pharmaceutical market czech republic

  • 1. The Pharmaceutical Market: Czech Republic OVERVIEW OF THE PHARMACEUTICAL MARKET IN CZECH REPUBLIC The recent measures proposed by the Czech Republic's Ministry of Health will, in all likelihood, negatively affect the Czech pharmaceutical market. The introduction of reimbursement ceilings, blind bidding auctions and preferential prescribing will squeeze drugmakers' margins and shift some of the burden of healthcare spending onto the private sector. The outcome of similar measures in Hungary and Poland strongly supports our view that the business environment for drugmakers will worsen if these proposals are adopted. It is patients who, ultimately, will suffer. Headline Expenditure Projections Pharmaceuticals: CZK80.71bn (US$4.56bn) in 2011 to CZK79.76bn (US$4.2bn) in 2012; -1.2% in local currency terms and -7.1% in US dollar terms. Healthcare: CZK298.49bn (US$16.88bn) in 2011 to CZK297.87bn (US$15.831bn) in 2012; +0.4% in local currency terms and -8.4% in US dollar terms. Medical Devices: CZK26.51n (US$1.50bn) in 2011 to CZK26.91bn (US$1.43bn) in 2012; +1.5% in local currency terms and -4.6% in US dollar terms. Forecast moderat ely down due to macroeconomic factors. Risk/Reward Rating The Czech Republic retains its leading position in the CEE RRRs in Q113, after displacing Poland in our Q412 assessment. Despite leading in our regional RRR table, the outlook for growth for the Czech pharmaceutical market is not particularly robust, as a result of pricing pressure, impeded market entry and increasing generic substitution. An increase in VAT and a stringent reference pricing system have affected sales and hit manufacturers' margins respectively. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors table Of Contents executive Summary 7 swot Analysis 9 czech Republic Pharmaceuticals And Healthcare Industry Swot 9 czech Republic Political Swot 10 czech Republic Economic Swot 10 czech Republic Business Environment Swot 10 pharmaceuticals Risk/reward Ratings 11 table: Central And Eastern Europe Pharmaceuticals Risk/reward Ratings, Q213 11 rewards 12 risks 12 czech Republic - Market Summary 14 regulatory Regime 16 intellectual Property Environment 16 prescribing Rules 17 pharmaceutical Advertising 17 The Pharmaceutical Market: Czech Republic
  • 2. pricing Regime 18 reimbursement Regime 19 recent Pricing And Reimbursement Developments 20 changes To Vat 22 table: European Vat Rates On Medicines (%) 23 industry Developments 25 epidemiology 25 healthcare Sector 26 healthcare Insurance 26 healthcare Reforms 27 hospital Sector 28 research & Development Sector 29 clinical Trials 30 medical Devices 31 industry Forecast Scenario 33 overall Market Forecast 33 table: Czech Pharmaceutical Sales, Historical Data And Forecasts 34 key Growth Factors - Industry 35 table: Czech Healthcare Expenditure Trends, Historical Data And Forecasts 36 table: Czech Government Healthcare Expenditure Trends, Historical Data And Forecasts 37 table: Czech Private Healthcare Expenditure Trends, Historical Data And Forecasts 37 key Growth Factors - Macroeconomic 38 prescription Drug Market Forecast 42 table: Czech Prescription Drug Market Indicators, Historical Data And Forecasts 43 patented Drug Market Forecast 44 table: Czech Patented Drug Market Indicators, Historical Data And Forecasts 45 generic Drug Market Forecast 46 table: Czech Generics Drug Market Indicators, Historical Data And Forecasts 46 The Pharmaceutical Market: Czech Republic
  • 3. otc Medicine Market Forecast 48 table: Czech Over-the-counter (otc) Medicine Market Indicators, Historical Data And Forecasts 50 pharmaceutical Trade Forecast 51 table: Czech Pharmaceutical Trade Data And Forecasts (us$mn) 52 table: Czech Pharmaceutical Trade Data And Forecasts (czkmn) 52 other Healthcare Data Forecasts 53 key Risks To Bmi's Forecast Scenario 53 competitive Landscape 54 pharmaceutical Sector 54 foreign Pharmaceutical Players 55 company Developments 55 pharmaceutical Wholesale 56 pharmaceutical Retail 57 table: Retail Pharmacy Market Overview, 2004-2010 57 pharmaceutical Distribution Developments 59 distance Selling Of Pharmaceuticals 60 company Profiles 61 local Companies 61 zentiva (sanofi) 61 walmark 64 multinational Companies 67 astrazeneca 67 bristol-myers Squibb 68 sanofi 69 novartis 71 glaxosmithkline 72 The Pharmaceutical Market: Czech Republic
  • 4. pfizer 74 demographic Outlook 75 table: Czech Republic's Population By Age Group, 1990-2020 ('000) 76 table: Czech Republic's Population By Age Group, 1990-2020 (% Of Total) 77 table: Czech Republic's Key Population Ratios, 1990-2020 78 table: Czech Republic's Rural And Urban Population, 1990-2020 78 glossary 79 bmi Methodology 81 how We Generate Our Pharmaceutical Industry Forecasts 81 pharmaceuticals Risk/reward Ratings Methodology 82 ratings Overview 82 table: Pharmaceutical Business Environment Indicators 83 weighting 84 table: Weighting Of Components 84 sources 84 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ The Pharmaceutical Market: Czech Republic